Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-11-16

AUTHORS

Masaubmi Shibuya

ABSTRACT

Vascular endothelial growth factor receptor-1 (VEGFR-1) is a member of the VEGFR family, and binds VEGF-A, PlGF, and VEGF-B. An important feature of VEGFR-1 is that, unlike other VEGFR genes, it expresses two types of mRNA, one for a full-length receptor and another for a soluble short protein known as soluble VEGFR-1 (sFlt-1). The binding-affinity of VEGFR-1 for VEGF-A is one order of magnitude higher than that of VEGFR-2, whereas the kinase activity of VEGFR-1 is about 10-fold weaker than that of VEGFR-2. Through its ligand-binding region and by trapping ligands, VEGFR-1 plays a negative role in angiogenesis at embryogenesis. In adulthood, however, VEGFR-1 is expressed not only on endothelial cells but also on macrophages, and promotes the function of macrophages, inflammatory diseases, cancer metastasis, and atherosclerosis via its kinase activity. Soluble VEGFR-1 is abnormally overexpressed in the placenta of preeclamptic patients, and suggested to cause the major pathological symptoms on the maternal side such as hypertension and renal dysfunction, most likely by blocking the physiological VEGF-A. VEGFR-1 including its soluble form is involved in a variety of human illnesses, making it an important target in the development of new strategies to suppress disease. More... »

PAGES

225-230

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10456-006-9055-8

DOI

http://dx.doi.org/10.1007/s10456-006-9055-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036908250

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17109193


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Down-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neovascularization, Pathologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neovascularization, Physiologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Up-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor Receptor-1", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, 108-8639, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Division of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, 108-8639, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shibuya", 
        "givenName": "Masaubmi", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nm1101-1194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050308225", 
          "https://doi.org/10.1038/nm1101-1194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/386671a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010094120", 
          "https://doi.org/10.1038/386671a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/376066a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032783732", 
          "https://doi.org/10.1038/376066a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm731", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043669041", 
          "https://doi.org/10.1038/nm731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001795574", 
          "https://doi.org/10.1038/nature04186"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-11-16", 
    "datePublishedReg": "2006-11-16", 
    "description": "Vascular endothelial growth factor receptor-1 (VEGFR-1) is a member of the VEGFR family, and binds VEGF-A, PlGF, and VEGF-B. An important feature of VEGFR-1 is that, unlike other VEGFR genes, it expresses two types of mRNA, one for a full-length receptor and another for a soluble short protein known as soluble VEGFR-1 (sFlt-1). The binding-affinity of VEGFR-1 for VEGF-A is one order of magnitude higher than that of VEGFR-2, whereas the kinase activity of VEGFR-1 is about 10-fold weaker than that of VEGFR-2. Through its ligand-binding region and by trapping ligands, VEGFR-1 plays a negative role in angiogenesis at embryogenesis. In adulthood, however, VEGFR-1 is expressed not only on endothelial cells but also on macrophages, and promotes the function of macrophages, inflammatory diseases, cancer metastasis, and atherosclerosis via its kinase activity. Soluble VEGFR-1 is abnormally overexpressed in the placenta of preeclamptic patients, and suggested to cause the major pathological symptoms on the maternal side such as hypertension and renal dysfunction, most likely by blocking the physiological VEGF-A. VEGFR-1 including its soluble form is involved in a variety of human illnesses, making it an important target in the development of new strategies to suppress disease.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10456-006-9055-8", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5934029", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.5769929", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1119026", 
        "issn": [
          "0969-6970", 
          "1573-7209"
        ], 
        "name": "Angiogenesis", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "vascular endothelial growth factor receptor 1", 
      "growth factor receptor 1", 
      "kinase activity", 
      "factor receptor 1", 
      "ligand-binding region", 
      "full-length receptor", 
      "soluble VEGFR-1", 
      "types of mRNA", 
      "shorter protein", 
      "VEGFR family", 
      "VEGFR genes", 
      "dual regulator", 
      "receptor 1", 
      "VEGFR-2", 
      "major pathological symptoms", 
      "function of macrophages", 
      "cancer metastasis", 
      "negative role", 
      "soluble form", 
      "preeclamptic patients", 
      "renal dysfunction", 
      "inflammatory diseases", 
      "endothelial cells", 
      "important target", 
      "maternal side", 
      "pathological symptoms", 
      "VEGF", 
      "human illness", 
      "angiogenesis", 
      "embryogenesis", 
      "disease", 
      "genes", 
      "macrophages", 
      "regulator", 
      "protein", 
      "mRNA", 
      "new strategy", 
      "hypertension", 
      "activity", 
      "cells", 
      "atherosclerosis", 
      "patients", 
      "PlGF", 
      "metastasis", 
      "dysfunction", 
      "symptoms", 
      "family", 
      "illness", 
      "placenta", 
      "receptors", 
      "members", 
      "target", 
      "adulthood", 
      "role", 
      "ligands", 
      "region", 
      "function", 
      "variety", 
      "development", 
      "important features", 
      "orders of magnitude", 
      "types", 
      "form", 
      "strategies", 
      "side", 
      "features", 
      "magnitude", 
      "order"
    ], 
    "name": "Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis", 
    "pagination": "225-230", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036908250"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10456-006-9055-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17109193"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10456-006-9055-8", 
      "https://app.dimensions.ai/details/publication/pub.1036908250"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_416.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10456-006-9055-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10456-006-9055-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10456-006-9055-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10456-006-9055-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10456-006-9055-8'


 

This table displays all metadata directly associated to this object as RDF triples.

184 TRIPLES      21 PREDICATES      106 URIs      92 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10456-006-9055-8 schema:about N004202f807374dbe88f7c4bed6e517fd
2 N2ded6a8104e942ff8a4ce8ac693d86c9
3 N64dd18483df34883a5061fc350dd9b69
4 N6a60276440fc4041b5a21bb078682f9c
5 N7a189dfb336847a9b1f55a9f424f5bf3
6 Na537aa8461044cc6871bf7c10247c82c
7 Nb12e90eca3df474fa90150b8b73ecb06
8 anzsrc-for:11
9 anzsrc-for:1103
10 anzsrc-for:1115
11 schema:author N97f544bc487b44239b730176879da458
12 schema:citation sg:pub.10.1038/376066a0
13 sg:pub.10.1038/386671a0
14 sg:pub.10.1038/nature04186
15 sg:pub.10.1038/nm1101-1194
16 sg:pub.10.1038/nm731
17 schema:datePublished 2006-11-16
18 schema:datePublishedReg 2006-11-16
19 schema:description Vascular endothelial growth factor receptor-1 (VEGFR-1) is a member of the VEGFR family, and binds VEGF-A, PlGF, and VEGF-B. An important feature of VEGFR-1 is that, unlike other VEGFR genes, it expresses two types of mRNA, one for a full-length receptor and another for a soluble short protein known as soluble VEGFR-1 (sFlt-1). The binding-affinity of VEGFR-1 for VEGF-A is one order of magnitude higher than that of VEGFR-2, whereas the kinase activity of VEGFR-1 is about 10-fold weaker than that of VEGFR-2. Through its ligand-binding region and by trapping ligands, VEGFR-1 plays a negative role in angiogenesis at embryogenesis. In adulthood, however, VEGFR-1 is expressed not only on endothelial cells but also on macrophages, and promotes the function of macrophages, inflammatory diseases, cancer metastasis, and atherosclerosis via its kinase activity. Soluble VEGFR-1 is abnormally overexpressed in the placenta of preeclamptic patients, and suggested to cause the major pathological symptoms on the maternal side such as hypertension and renal dysfunction, most likely by blocking the physiological VEGF-A. VEGFR-1 including its soluble form is involved in a variety of human illnesses, making it an important target in the development of new strategies to suppress disease.
20 schema:genre article
21 schema:isAccessibleForFree false
22 schema:isPartOf N52f0065f768744aabef92c2f2a780dae
23 Ne4bc1598bc9d4dccaac087711be34d18
24 sg:journal.1119026
25 schema:keywords PlGF
26 VEGF
27 VEGFR family
28 VEGFR genes
29 VEGFR-2
30 activity
31 adulthood
32 angiogenesis
33 atherosclerosis
34 cancer metastasis
35 cells
36 development
37 disease
38 dual regulator
39 dysfunction
40 embryogenesis
41 endothelial cells
42 factor receptor 1
43 family
44 features
45 form
46 full-length receptor
47 function
48 function of macrophages
49 genes
50 growth factor receptor 1
51 human illness
52 hypertension
53 illness
54 important features
55 important target
56 inflammatory diseases
57 kinase activity
58 ligand-binding region
59 ligands
60 mRNA
61 macrophages
62 magnitude
63 major pathological symptoms
64 maternal side
65 members
66 metastasis
67 negative role
68 new strategy
69 order
70 orders of magnitude
71 pathological symptoms
72 patients
73 placenta
74 preeclamptic patients
75 protein
76 receptor 1
77 receptors
78 region
79 regulator
80 renal dysfunction
81 role
82 shorter protein
83 side
84 soluble VEGFR-1
85 soluble form
86 strategies
87 symptoms
88 target
89 types
90 types of mRNA
91 variety
92 vascular endothelial growth factor receptor 1
93 schema:name Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis
94 schema:pagination 225-230
95 schema:productId N14928faa55a34bf3995b4ff43820bb7e
96 N4ee254f37bf348fca2447729dd5ff132
97 N79ec7006862e45638ef07244d4bba850
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036908250
99 https://doi.org/10.1007/s10456-006-9055-8
100 schema:sdDatePublished 2022-09-02T15:52
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher N988205f838644bd48987a8225ab66b3d
103 schema:url https://doi.org/10.1007/s10456-006-9055-8
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N004202f807374dbe88f7c4bed6e517fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Humans
109 rdf:type schema:DefinedTerm
110 N14928faa55a34bf3995b4ff43820bb7e schema:name dimensions_id
111 schema:value pub.1036908250
112 rdf:type schema:PropertyValue
113 N2ded6a8104e942ff8a4ce8ac693d86c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Neovascularization, Physiologic
115 rdf:type schema:DefinedTerm
116 N4ee254f37bf348fca2447729dd5ff132 schema:name doi
117 schema:value 10.1007/s10456-006-9055-8
118 rdf:type schema:PropertyValue
119 N52f0065f768744aabef92c2f2a780dae schema:issueNumber 4
120 rdf:type schema:PublicationIssue
121 N5a9898792d2f4db7a066883e4a220401 schema:affiliation grid-institutes:grid.26999.3d
122 schema:familyName Shibuya
123 schema:givenName Masaubmi
124 rdf:type schema:Person
125 N64dd18483df34883a5061fc350dd9b69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Down-Regulation
127 rdf:type schema:DefinedTerm
128 N6a60276440fc4041b5a21bb078682f9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Up-Regulation
130 rdf:type schema:DefinedTerm
131 N79ec7006862e45638ef07244d4bba850 schema:name pubmed_id
132 schema:value 17109193
133 rdf:type schema:PropertyValue
134 N7a189dfb336847a9b1f55a9f424f5bf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Animals
136 rdf:type schema:DefinedTerm
137 N97f544bc487b44239b730176879da458 rdf:first N5a9898792d2f4db7a066883e4a220401
138 rdf:rest rdf:nil
139 N988205f838644bd48987a8225ab66b3d schema:name Springer Nature - SN SciGraph project
140 rdf:type schema:Organization
141 Na537aa8461044cc6871bf7c10247c82c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Vascular Endothelial Growth Factor Receptor-1
143 rdf:type schema:DefinedTerm
144 Nb12e90eca3df474fa90150b8b73ecb06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Neovascularization, Pathologic
146 rdf:type schema:DefinedTerm
147 Ne4bc1598bc9d4dccaac087711be34d18 schema:volumeNumber 9
148 rdf:type schema:PublicationVolume
149 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
150 schema:name Medical and Health Sciences
151 rdf:type schema:DefinedTerm
152 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
153 schema:name Clinical Sciences
154 rdf:type schema:DefinedTerm
155 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
156 schema:name Pharmacology and Pharmaceutical Sciences
157 rdf:type schema:DefinedTerm
158 sg:grant.5769929 http://pending.schema.org/fundedItem sg:pub.10.1007/s10456-006-9055-8
159 rdf:type schema:MonetaryGrant
160 sg:grant.5934029 http://pending.schema.org/fundedItem sg:pub.10.1007/s10456-006-9055-8
161 rdf:type schema:MonetaryGrant
162 sg:journal.1119026 schema:issn 0969-6970
163 1573-7209
164 schema:name Angiogenesis
165 schema:publisher Springer Nature
166 rdf:type schema:Periodical
167 sg:pub.10.1038/376066a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032783732
168 https://doi.org/10.1038/376066a0
169 rdf:type schema:CreativeWork
170 sg:pub.10.1038/386671a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010094120
171 https://doi.org/10.1038/386671a0
172 rdf:type schema:CreativeWork
173 sg:pub.10.1038/nature04186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001795574
174 https://doi.org/10.1038/nature04186
175 rdf:type schema:CreativeWork
176 sg:pub.10.1038/nm1101-1194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050308225
177 https://doi.org/10.1038/nm1101-1194
178 rdf:type schema:CreativeWork
179 sg:pub.10.1038/nm731 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043669041
180 https://doi.org/10.1038/nm731
181 rdf:type schema:CreativeWork
182 grid-institutes:grid.26999.3d schema:alternateName Division of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, 108-8639, Tokyo, Japan
183 schema:name Division of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, 108-8639, Tokyo, Japan
184 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...